Real World Efficacy and Safety Results of Ixazomib Lenalidomide and Dexamethasone Combination in Relapsed/Refractory Multiple Myeloma: Data Collected from the Hungarian Ixazomib Named Patient Program
-
Published:2019-02-02
Issue:4
Volume:25
Page:1615-1620
-
ISSN:1219-4956
-
Container-title:Pathology & Oncology Research
-
language:en
-
Short-container-title:Pathol. Oncol. Res.
Author:
Varga GergelyORCID, Nagy Zsolt, Demeter Judit, Kosztolányi Szabolcs, Szomor Árpád, Alizadeh Hussain, Deák Beáta, Schneider Tamás, Plander Márk, Szendrei Tamás, Váróczy László, Illés Árpád, Bátai Árpád, Pető Mónika, Mikala Gábor
Funder
Semmelweis University
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology,General Medicine,Pathology and Forensic Medicine
Reference12 articles.
1. Moreau P, Masszi T, Grzasko N, Bahlis NJ, Hansson M, Pour L, Sandhu I, Ganly P, Baker BW, Jackson SR, Stoppa AM, Simpson DR, Gimsing P, Palumbo A, Garderet L, Cavo M, Kumar S, Touzeau C, Buadi FK, Laubach JP, Berg DT, Lin J, di Bacco A, Hui AM, van de Velde H, Richardson PG (2016) Oral Ixazomib, Lenalidomide, and dexamethasone for multiple myeloma. N Engl J Med 374(17):1621–1634 2. Mateos MV, Masszi T, Grzasko N, Hansson M, Sandhu I, Pour L, Viterbo L, Jackson SR, Stoppa AM, Gimsing P, Hamadani M, Borsaru G, Berg D, Lin J, di Bacco A, van de Velde H, Richardson PG, Moreau P (2017) Impact of prior therapy on the efficacy and safety of oral ixazomib-lenalidomide-dexamethasone vs. placebo-lenalidomide-dexamethasone in patients with relapsed/refractory multiple myeloma in TOURMALINE-MM1. Haematologica 102(10):1767–1775 3. Al-Salama ZT, Garnock-Jones KP, Scott LJ (2017) Ixazomib: a review in relapsed and/or refractory multiple myeloma. Target Oncol 12(4):535–542 4. Terpos E, Maouche N, Minarik J et al (2017) "Real world" data on the efficacy and safety of Ixazomib in combination with Lenalidomide and dexamethasone in relapsed/refractory multiple myeloma: a combined study from the Greek, Czech and UK databases. Blood, 130(Suppl 1), 3087 5. Ziff M, Cheesman S, Kyriakou C (2017) Real world use of ixazomib with lenalidomide and dexamethasone for patients with relapsed and relapsed refractory multiple myeloma. EHA 2017 Abstract 1975
Cited by
24 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|